Research
Hormonal
Semaglutide treatment following catheter ablation for atrial fibrillation is associated with a lower rate of atrial arrhythmia recurrence over 12 months (hazard ratio, 0.68; P =0.030).
Practitioners may consider semaglutide as a therapeutic option to reduce atrial arrhythmia recurrence post-ablation.
StrongSupportsmedium confidence
During the 12-month follow-up, the semaglutide group showed a higher event-free rate for recurrent atrial arrhythmias (hazard ratio, 0.68 [95% CI, 0.49–0.95]; P =0.030).
Why this rating
The study is a prospective cohort with a significant sample size.
Source
Effect of Semaglutide on Atrial Arrhythmias Recurrence Following Ablation for Atrial Fibrillation: A Prospective Study
Jiongchao Guo et al. · Circulation Arrhythmia and Electrophysiology · 2025
cohort · n=437Cited 6×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →